×
About 2,478 results

ALLMedicine™ Amphetamines Center

Research & Reviews  692 results

Medical marijuana legalization in Oklahoma: Effects on neonatal exposure to opiates.
https://doi.org/10.1055/a-1990-8311
American Journal of Perinatology; DeShea L, Rolfs S et. al.

Dec 2nd, 2022 - The US opioid epidemic has been characterized by increases in opioid misuse, overdose deaths, and neonatal opioid withdrawal syndrome. Research suggests that marijuana legalization has contributed to decreased use of opiates, although many studies...

False-Positive Amphetamines in Urine Drug Screens: A Six-Year Review.
https://doi.org/10.1093/jat/bkac089
Journal of Analytical Toxicology; Pope JD, Drummer OH et. al.

Nov 12th, 2022 - Immunoassays are routinely used to provide rapid urine drug screening results in the clinical setting. These screening tests are prone to false positive results and ideally require confirmation by mass spectrometry. In this study, we have examined...

Cannabis use disorder in chronic pain patients: over- and underestimation in a cross-se...
https://doi.org/10.1097/j.pain.0000000000002817
Pain Bialas P, Böttge-Wolpers C et. al.

Nov 4th, 2022 - There are concerns that cannabis use disorder (CUD) may develop in chronic pain patients prescribed medical cannabis (MC). The criteria for CUD according to the Statistical Manual for Mental Disorders Version 5 (DSM-5) were not developed for ident...

Open-label Conditioning Therapy for Peri-operative Pain Management in Head and Neck Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT04973748

Oct 13th, 2022 - Primary Objective Determine feasibility of open-label randomized controlled trial of conditioning therapy for post-operative pain management in complex head and neck cancer patients. Rationale: Conditioning therapy with placebo has been studied an...

Amphetamine-Related Psychiatric Disorders
https://emedicine.medscape.com/article/289973-overview

Oct 12th, 2022 - Background The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) describes the following 11 amphetamine-related psychiatric disorders: [1] Amphetamine-induced anxiety disorder Amphetamine-induced bipola...

see more →

Guidelines  1 results

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendation...
https://www.ncbi.nlm.nih.gov/pubmed/22303521
Annals of Clinical Psychiatry : Official Journal of the A... Beaulieu S, Saury S et. al.

Feb 4th, 2012 - Mood disorders, especially bipolar disorder (BD), frequently are associated with substance use disorders (SUDs). There are well-designed trials for the treatment of SUDs in the absence of a comorbid condition. However, one cannot generalize these ...

see more →

Drugs  76 results see all →

Clinicaltrials.gov  53 results

Open-label Conditioning Therapy for Peri-operative Pain Management in Head and Neck Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT04973748

Oct 13th, 2022 - Primary Objective Determine feasibility of open-label randomized controlled trial of conditioning therapy for post-operative pain management in complex head and neck cancer patients. Rationale: Conditioning therapy with placebo has been studied an...

Effects of Dronabinol in Opioid Maintained Patients
https://clinicaltrials.gov/ct2/show/NCT04025359

Sep 30th, 2022 - This is a double-blind, randomized, placebo-controlled cross-over human laboratory study. Participants will be asked to come to the testing site for a total of four times: one initial screening session (~ 3 hours) and three test days (~ 6 hours ea...

Blood Vessel Study
https://clinicaltrials.gov/ct2/show/NCT01524549

Sep 19th, 2022 - According to the CDC, heart disease is the leading cause of death for both men and women of most racial/ethnic groups in the United States, including African Americans, Hispanics, and whites. About 610,000 people die of cardiovascular disease (CVD...

Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis
https://clinicaltrials.gov/ct2/show/NCT01615887

Sep 16th, 2022 - Amphetamines have been shown to improve cognition but its use is limited due to its side effects. Lisdexamfetamine is an amphetamine pro-drug, minimizing these effects and has been safely used in children and adults with Attention Deficit Hyperact...

Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
https://clinicaltrials.gov/ct2/show/NCT04791969

Sep 9th, 2022 - Methamphetamine (meth) use is very common among men who have sex with men (MSM), particularly MSM living with HIV. Meth use among HIV-negative and HIV-positive MSM is up to 13 and 34 times more prevalent than in the general U.S. adult population, ...

see more →

News  159 results

New Auvelity Data; Yale's Mental Health Lawsuit; Depression Nasal Spray Fast-Tracked
https://www.medpagetoday.com/psychiatry/generalpsychiatry/102115

Dec 7th, 2022 - The antidepressant dextromethorphan HBr-bupropion HCl (Auvelity) achieved rapid and sustained improvements in both cognitive and physical functioning in people with major depressive disorder in the 12-month EVOLVE trial, Axsome Therapeutics announ...

Punitive Policies for Substance Use in Pregnancy Tied to Worse Obstetric Care
https://www.medpagetoday.com/obgyn/pregnancy/100807

Sep 19th, 2022 - Women who lived in states with policies that punished women for substance use during pregnancy received worse prenatal and postpartum care, according to a cross-sectional study. Patients in states that considered substance use during pregnancy a f...

Skin-picking, hair-pulling disorders: Diagnostic criteria, prevalence, and treatment
https://www.mdedge.com/dermatology/article/256748/pediatrics/skin-picking-hair-pulling-disorders-diagnostic-criteria
Doug Brunk

Aug 2nd, 2022 - INDIANAPOLIS – Despite the common prevalence of skin-picking disorder and trichotillomania (hair pulling), no Food and Drug Administration–approved treatments exist for either condition. And while both body-focused repetitive behavior disorders af.

Treatment Options Limited for Skin-Picking, Hair-Pulling Disorders
https://www.medscape.com/viewarticle/978447

Aug 2nd, 2022 - INDIANAPOLIS – Despite the common prevalence of skin-picking disorder and trichotillomania (hair pulling), no Food and Drug Administration–approved treatments exist for either condition. And while both body-focused repetitive behavior disorders af...

Cannabis Use Has Risen With Legalization and COVID Lockdowns: UN Report
https://www.medscape.com/viewarticle/976220

Jun 28th, 2022 - VIENNA (Reuters) - Places including U.S. states that have legalized cannabis appear to have increased its regular use, while COVID lockdowns had a similar effect, raising the risk of depression and suicide, a U.N. report said on Monday. Cannabis h...

see more →

Patient Education  10 results see all →